Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 164,307 | 23,904 | 6,176 | 1,030 | 0 |
| Gross Profit | 164,307 | 23,904 | 6,176 | 1,030 | N/A |
| Operating Expenses | 277,515 | 152,090 | 96,528 | 61,769 | 59,748 |
| Operating Income | -113,208 | -128,186 | -90,352 | -60,739 | -59,748 |
| Interest Expense | 20 | 3 | 603 | 0 | 0 |
| Other Income | 481 | 7,730 | 2,102 | 539 | 235 |
| Pre-tax Income | -112,747 | -120,459 | -88,853 | -60,200 | -59,513 |
| Net Income Continuous | -112,747 | -120,459 | -88,853 | -60,200 | -59,513 |
| Net Income | $-112,747 | $-120,459 | $-88,853 | $-60,200 | $-59,513 |
| EPS Basic Total Ops | -1.52 | -1.76 | -1.60 | -3.66 | -2.87 |
| EPS Basic Continuous Ops | -1.52 | -1.76 | -1.60 | -2.75 | -2.87 |
| EPS Diluted Total Ops | -1.52 | -1.76 | -1.60 | -3.66 | -2.87 |
| EPS Diluted Continuous Ops | -1.52 | -1.76 | -1.60 | -2.75 | -2.87 |
| EPS Diluted Before Non-Recurring Items | -1.52 | -1.76 | -1.20 | -3.66 | -2.87 |
| EBITDA(a) | $-110,618 | $-130,491 | $-90,704 | $-60,130 | $-58,835 |